Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients

• Main Authors: Yansong Liu, Xiaoqian Fu, Zhen Tang, Cui Li, Yong Xu, Fuquan Zhang, Deyi Zhou, Chunming Zhu
• Format: Article
• Language: English
• Published: BMC 2019-04-01
• Series: BMC Psychiatry
• Subjects: Schizophrenia; CSMD1; Antipsychotics
• Online Access: http://link.springer.com/article/10.1186/s12888-019-2089-4

Abstract Background Schizophrenia (SCZ) is a heritable, refractory, and devastating psychiatric disorder. Previous studies have shown that the variants of CUB and sushi multiple domains 1 (CSMD1) demonstrate significant genome-wide association with SCZ. However, few studies have been conducted on the effect of antipsychotics on the expression levels of CSMD1. This study explored whether a change occurs in the expression of the CSMD1 gene before and after antipsychotic treatment in SCZ patients. Methods The study population comprised Han Chinese patients from eastern China, including 32 SCZ patients and 48 healthy controls. The expression of CSMD1 before and after treatment in the SCZ group and between the two groups was analyzed using real-time quantitative polymerase chain reaction (RT-qPCR). Results The expression levels of the CSMD1 gene in the peripheral blood mononuclear cells (PBMCs) of SCZ patients were lower than those in the healthy controls. The expression levels of the CSMD1 gene in the PBMCs of the SCZ patients after antipsychotic treatment were higher than those in the baseline SCZ patients (all P <  0.05). Conclusions Our results showed that the expression levels of CSMD1 are correlated with the development and treatment of SCZ, providing further evidence for the involvement of CSMD1 in SCZ.